Statistics for A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Total visits
| views | |
|---|---|
| A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782) | 3 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:c32d15c9-38e8-49f3-b48c-92803e8f904d | 34 |
| java.util.UUID:6e8e2447-e2e7-4d13-bbf1-32dee0a1d094 | 20 |
| Leal2022Phase1-CCBY.pdf | 11 |
| java.util.UUID:ad000d98-7fe7-4618-b709-d87420d4d622 | 11 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Greenwood | 3 |